Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Catalent expands SteraMist disinfection across U.S. locations » 08:41
06/07/21
06/07
08:41
06/07/21
08:41
TOMZ

TOMI Environmental Solutions

$2.72 /

-0.04 (-1.45%)

, CTLT

Catalent

$101.19 /

+0.56 (+0.56%)

TOMI Environmental…

TOMI Environmental Solutions (TOMZ) announced the implementation of SteraMist technology into four Catalent (CTLT) facilities, and a planned expansion into a fifth location. In October 2018, the company's first purchase order was for an Environment System and a Surface Unit. Shortly after, in May 2019, having experienced firsthand the direct advantages of SteraMist, Catalent purchased six additional Environment Systems and an additional Surface Unit for its BioPark and Harmans facilities. Recently, TOMI received an additional six-figure purchase order from Catalent for additional SteraMist units. Catalent has also turned to TOMI's iHP Corporate Service team to decontaminate one of their facilities, resulting in additional revenue. Furthermore, Catalent is planning to install a Custom Engineered System for use within their material airlocks. Catalent has also expressed interest in purchasing several SteraMist Select Plus units for their facilities once testing is completed. The SteraMist Select Plus is currently under development by TOMI as a hybrid product consisting of the Company's current Surface Select and Environment systems. The unit will allow for enhanced flexibility by using a single applicator to decontaminate full-room to small-space volume while maintaining the size of the current Surface unit with more robust process controls.

ShowHide Related Items >><<
TOMZ TOMI Environmental Solutions
$2.72 /

-0.04 (-1.45%)

CTLT Catalent
$101.19 /

+0.56 (+0.56%)

TOMZ TOMI Environmental Solutions
$2.72 /

-0.04 (-1.45%)

CTLT Catalent
$101.19 /

+0.56 (+0.56%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
CTLT Catalent
$101.19 /

+0.56 (+0.56%)

  • 23
    Nov
  • 11
    Jun
CTLT Catalent
$101.19 /

+0.56 (+0.56%)

CTLT Catalent
$101.19 /

+0.56 (+0.56%)

Over a week ago
Periodicals
AstraZeneca talking move of COVID vaccine production to Catalent plant, NYT says » 15:17
06/02/21
06/02
15:17
06/02/21
15:17
AZN

AstraZeneca

$56.11 /

-0.145 (-0.26%)

, CTLT

Catalent

$100.80 /

-1.3 (-1.27%)

, EBS

Emergent BioSolutions

$61.77 /

+0.02 (+0.03%)

AstraZeneca (AZN) is…

AstraZeneca (AZN) is negotiating with the federal government to shift production of its coronavirus vaccine from Emergent BioSolutions (EBS), which was forced more than six weeks ago to stop manufacturing AstraZeneca's vaccine, to a factory owned by Catalent (CTLT), according to The New York Times' Noah Weiland, Sharon LaFraniere and Sheryl Gay Stolberg, citing people familiar with the plans. Reference Link

ShowHide Related Items >><<
EBS Emergent BioSolutions
$61.77 /

+0.02 (+0.03%)

CTLT Catalent
$100.80 /

-1.3 (-1.27%)

AZN AstraZeneca
$56.11 /

-0.145 (-0.26%)

AZN AstraZeneca
$56.11 /

-0.145 (-0.26%)

06/01/21 Piper Sandler
Piper sees 'quite real' chance of Akebia's vadadustat being first HIF approved
05/05/21 Oppenheimer
Alexion upgraded to Outperform from Perform at Oppenheimer
04/30/21 Wedbush
Alexion's Q1 report 'uneventful' after FTC grants deal clearance, says Wedbush
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
CTLT Catalent
$100.80 /

-1.3 (-1.27%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
EBS Emergent BioSolutions
$61.77 /

+0.02 (+0.03%)

05/05/21 Wells Fargo
Emergent BioSolutions price target lowered to $64 from $70 at Wells Fargo
05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
04/30/21 Chardan
Emergent BioSolutions price target lowered to $92 from $112 at Chardan
EBS Emergent BioSolutions
$61.77 /

+0.02 (+0.03%)

CTLT Catalent
$100.80 /

-1.3 (-1.27%)

AZN AstraZeneca
$56.11 /

-0.145 (-0.26%)

  • 23
    Nov
  • 11
    Jun
EBS Emergent BioSolutions
$61.77 /

+0.02 (+0.03%)

CTLT Catalent
$100.80 /

-1.3 (-1.27%)

AZN AstraZeneca
$56.11 /

-0.145 (-0.26%)

EBS Emergent BioSolutions
$61.77 /

+0.02 (+0.03%)

CTLT Catalent
$100.80 /

-1.3 (-1.27%)

AZN AstraZeneca
$56.11 /

-0.145 (-0.26%)

AZN AstraZeneca
$56.11 /

-0.145 (-0.26%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/26/21
05/26
04:55
05/26/21
04:55
NBTX

Nanobiotix

$16.16 /

+ (+0.00%)

, MRNA

Moderna

$169.25 /

+5.16 (+3.14%)

, TELA

Tela Bio

$13.85 /

+0.6 (+4.53%)

, ICLR

Icon

$229.34 /

-2.74 (-1.18%)

, AMWL

Amwell

$11.89 /

+0.38 (+3.30%)

, BRKR

Bruker

$69.86 /

+0.12 (+0.17%)

, SIOX

Sio Gene Therapies

$2.22 /

+0.01 (+0.45%)

, BMRN

BioMarin

$77.60 /

+0.08 (+0.10%)

, NVS

Novartis

$88.51 /

+0.51 (+0.58%)

, TERN

Terns Pharmaceuticals

$15.39 /

-0.62 (-3.87%)

, EAR

Eargo

$32.10 /

-1.12 (-3.37%)

, JAZZ

Jazz Pharmaceuticals

$177.71 /

-1.17 (-0.65%)

, TNDM

TNDM

/

+

, BAYRY

Bayer

$16.93 /

-0.265 (-1.54%)

, ANIK

Anika Therapeutics

$43.66 /

-0.55 (-1.24%)

, CVAC

CureVac

$115.64 /

+1.27 (+1.11%)

, BSX

Boston Scientific

$43.03 /

+0.215 (+0.50%)

, APLT

Applied Therapeutics

$18.57 /

+1.06 (+6.05%)

, ARVN

Arvinas

$65.15 /

-0.78 (-1.18%)

, PACB

Pacific Biosciences

$25.68 /

-0.1 (-0.39%)

, ABBV

AbbVie

$114.56 /

-1.35 (-1.16%)

, ZYXI

Zynex

$14.12 /

-0.61 (-4.14%)

, BAX

Baxter

$82.34 /

-0.42 (-0.51%)

, KOD

Kodiak Sciences

$82.62 /

+1.66 (+2.05%)

, ARWR

Arrowhead

$73.96 /

-0.83 (-1.11%)

, CUTR

Cutera

$36.98 /

-1.15 (-3.02%)

, TVTY

Tivity Health

$25.73 /

-0.09 (-0.35%)

, PTCT

PTC Therapeutics

$39.66 /

+0.52 (+1.33%)

, CTLT

Catalent

$103.45 /

+0.88 (+0.86%)

, RHHBY

Roche

$43.57 /

+ (+0.00%)

, CLPT

ClearPoint Neuro

$18.07 /

-0.38 (-2.06%)

, BNTX

BioNTech

$197.53 /

+2.64 (+1.35%)

, ALGN

Align Technology

$594.91 /

-9.47 (-1.57%)

, DBTX

Decibel Therapeutics

$7.85 /

-0.205 (-2.55%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2021 to be held on May 24-26.Webcast Link

ShowHide Related Items >><<
ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

TVTY Tivity Health
$25.73 /

-0.09 (-0.35%)

TNDM TNDM
/

+

TERN Terns Pharmaceuticals
$15.39 /

-0.62 (-3.87%)

TELA Tela Bio
$13.85 /

+0.6 (+4.53%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

RHHBY Roche
$43.57 /

+ (+0.00%)

PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

KOD Kodiak Sciences
$82.62 /

+1.66 (+2.05%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

DBTX Decibel Therapeutics
$7.85 /

-0.205 (-2.55%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CUTR Cutera
$36.98 /

-1.15 (-3.02%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BRKR Bruker
$69.86 /

+0.12 (+0.17%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
MRNA Moderna
$169.25 /

+5.16 (+3.14%)

05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
05/07/21 Goldman Sachs
Moderna price target raised to $228 from $206 at Goldman Sachs
05/06/21 Piper Sandler
Moderna price target lowered to $231 from $234 at Piper Sandler
TELA Tela Bio
$13.85 /

+0.6 (+4.53%)

04/12/21 Piper Sandler
Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
03/25/21 Canaccord
Tela Bio pieces in place for accelerating growth, says Canaccord
01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
ICLR Icon
$229.34 /

-2.74 (-1.18%)

05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/03/21 Mizuho
Icon price target raised to $242 from $217 at Mizuho
04/29/21 Credit Suisse
Icon price target raised to $245 from $240 at Credit Suisse
04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
AMWL Amwell
$11.89 /

+0.38 (+3.30%)

05/17/21 Guggenheim
Amwell upgraded to Buy from Neutral at Guggenheim
05/13/21 Piper Sandler
Amwell price target lowered to $20 from $30 at Piper Sandler
05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
BRKR Bruker
$69.86 /

+0.12 (+0.17%)

05/06/21 BTIG
Bruker price target raised to $80 from $73 at BTIG
05/06/21 SVB Leerink
Bruker price target raised to $80 from $70 at SVB Leerink
02/17/21 Stifel
Bruker price target raised to $65 from $48 at Stifel
02/17/21 Citi
Bruker price target raised to $65 from $57 at Citi
SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

04/30/21 Wedbush
BioMarin's Q1 revenue was better than expected, says Wedbush
04/26/21 Credit Suisse
BioMarin assumed with an Outperform at Credit Suisse
03/04/21 Guggenheim
BioMarin assumed at Buy from Neutral at Guggenheim
03/01/21 Evercore ISI
BioMarin upgraded to Outperform from In Line at Evercore ISI
NVS Novartis
$88.51 /

+0.51 (+0.58%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
TERN Terns Pharmaceuticals
$15.39 /

-0.62 (-3.87%)

03/02/21 Cowen
Terns initiated with Outperform on NASH potential at Cowen
03/02/21 JPMorgan
Terns Pharmaceuticals initiated with an Overweight at JPMorgan
03/02/21 Cowen
Terns Pharmaceuticals initiated with an Outperform at Cowen
03/02/21 Goldman Sachs
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs
EAR Eargo
$32.10 /

-1.12 (-3.37%)

05/13/21 Wells Fargo
Eargo price target lowered to $52 from $68 at Wells Fargo
05/12/21 JPMorgan
JPMorgan sees four 'compelling' MedTech opportunities after selloff
01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
TNDM TNDM
/

+

05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Tandem Diabetes initiated with an Underweight at Barclays
05/06/21 SVB Leerink
Tandem Diabetes price target raised to $102 from $95 at SVB Leerink
05/06/21 Oppenheimer
Tandem Diabetes price target raised to $135 from $130 at Oppenheimer
BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

05/19/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
05/19/21 JPMorgan
JPMorgan upgrades Bayer to Overweight with earnings at 'turning point'
05/18/21 JPMorgan
Bayer upgraded to Overweight from Neutral at JPMorgan
05/14/21 Berenberg
Bayer price target raised to EUR 74 from EUR 68 at Berenberg
ANIK Anika Therapeutics
$43.66 /

-0.55 (-1.24%)

12/16/20 Barrington
Anika Therapeutics upgraded to Outperform with $43 target at Barrington
12/16/20 Barrington
Anika Therapeutics upgraded to Outperform from Market Perform at Barrington
CVAC CureVac
$115.64 /

+1.27 (+1.11%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

05/24/21 Barclays
Boston Scientific initiated with an Overweight at Barclays
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Truist
Boston Scientific price target raised to $50 from $42 at Truist
APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

11/17/20 Barclays
Applied Therapeutics price target lowered to $44 from $64 at Barclays
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

05/20/21 UBS
Arvinas initiated with a Buy at UBS
04/21/21 Truist
Truist starts Arvinas with a Buy on PROTACs potential
04/21/21 Truist
Arvinas initiated with a Buy at Truist
03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
02/26/21 B. Riley
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
02/26/21 B. Riley
Zynex downgraded to Neutral from Buy at B. Riley Securities
BAX Baxter
$82.34 /

-0.42 (-0.51%)

05/24/21 Barclays
Baxter initiated with an Equal Weight at Barclays
04/30/21 Citi
Baxter price target raised to $98 from $94 at Citi
04/29/21 Piper Sandler
Baxter price target raised to $85 from $80 at Piper Sandler
KOD Kodiak Sciences
$82.62 /

+1.66 (+2.05%)

05/11/21 Roth Capital
Roth Capital upgrades Kodiak Sciences to Buy on recent selloff
05/11/21 Roth Capital
Kodiak Sciences upgraded to Buy from Neutral at Roth Capital
05/11/21 BMO Capital
Kodiak Sciences price target lowered to $104 from $138 at BMO Capital
05/11/21 Barclays
Kodiak Sciences price target lowered to $86 from $90 at Barclays
ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

02/08/21 B. Riley
Arrowhead price target raised to $106 from $98 at B. Riley Securities
02/08/21 Citi
Arrowhead price target raised to $110 from $90 at Citi
02/05/21 Chardan
Arrowhead price target raised to $97 from $81 at Chardan
02/05/21 H.C. Wainwright
Arrowhead price target raised to $95 from $90 at H.C. Wainwright
CUTR Cutera
$36.98 /

-1.15 (-3.02%)

03/05/21 Piper Sandler
Cutera price target raised to $42 from $38 at Piper Sandler
02/18/21 Piper Sandler
Cutera price target raised to $38 from $28 at Piper Sandler
11/05/20 Piper Sandler
Cutera price target raised to $28 from $22 at Piper Sandler
09/14/20 Stephens
Cutera price target raised to $24 from $18 at Stephens
TVTY Tivity Health
$25.73 /

-0.09 (-0.35%)

02/25/21 Barrington
Tivity Health price target raised to $32 from $28 at Barrington
02/25/21 Piper Sandler
Tivity Health price target raised to $27 from $16 at Piper Sandler
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform with $19 target at Credit Suisse
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform from Neutral at Credit Suisse
PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

05/17/21 Truist
PTC Therapeutics price target lowered to $65 from $75 at Truist
04/26/21 Credit Suisse
PTC Therapeutics assumed with a Neutral at Credit Suisse
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
CTLT Catalent
$103.45 /

+0.88 (+0.86%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
RHHBY Roche
$43.57 /

+ (+0.00%)

05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

03/18/21 Lake Street
Lake Street starts ClearPoint Neuro at Buy, sees 'billion-dollar' cap potential
03/18/21 Lake Street
ClearPoint Neuro initiated with a Buy at Lake Street
02/22/21 B. Riley
ClearPoint Neuro price target raised to $38 from $23 at B. Riley Securities
01/22/21 B. Riley
ClearPoint Neuro price target raised to $23 from $18 at B. Riley Securities
BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21
Fly Intel: Top five analyst downgrades
ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

04/29/21 SVB Leerink
Align Technology price target raised to $770 from $690 at SVB Leerink
04/29/21 Credit Suisse
Align Technology price target raised to $715 from $693 at Credit Suisse
04/29/21 Stifel
Align Technology price target raised to $750 from $650 at Stifel
04/29/21 Baird
Align Technology price target raised to $745 from $655 at Baird
DBTX Decibel Therapeutics
$7.85 /

-0.205 (-2.55%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

TVTY Tivity Health
$25.73 /

-0.09 (-0.35%)

TNDM TNDM
/

+

TELA Tela Bio
$13.85 /

+0.6 (+4.53%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

RHHBY Roche
$43.57 /

+ (+0.00%)

PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

KOD Kodiak Sciences
$82.62 /

+1.66 (+2.05%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

EAR Eargo
$32.10 /

-1.12 (-3.37%)

CUTR Cutera
$36.98 /

-1.15 (-3.02%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BRKR Bruker
$69.86 /

+0.12 (+0.17%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

  • 19
    Feb
  • 12
    Feb
  • 12
    Feb
  • 05
    Feb
  • 28
    Jan
  • 15
    Jan
  • 16
    Dec
  • 11
    Dec
  • 23
    Nov
  • 18
    Nov
  • 11
    Nov
  • 21
    Oct
  • 16
    Oct
  • 17
    Sep
  • 12
    Aug
  • 14
    Aug
  • 23
    Jul
  • 15
    Jul
  • 26
    Jun
  • 11
    Jun
RHHBY Roche
$43.57 /

+ (+0.00%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

TERN Terns Pharmaceuticals
$15.39 /

-0.62 (-3.87%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

RHHBY Roche
$43.57 /

+ (+0.00%)

PTCT PTC Therapeutics
$39.66 /

+0.52 (+1.33%)

NVS Novartis
$88.51 /

+0.51 (+0.58%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

JAZZ Jazz Pharmaceuticals
$177.71 /

-1.17 (-0.65%)

ICLR Icon
$229.34 /

-2.74 (-1.18%)

DBTX Decibel Therapeutics
$7.85 /

-0.205 (-2.55%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CTLT Catalent
$103.45 /

+0.88 (+0.86%)

CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BRKR Bruker
$69.86 /

+0.12 (+0.17%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

BMRN BioMarin
$77.60 /

+0.08 (+0.10%)

BAYRY Bayer
$16.93 /

-0.265 (-1.54%)

BAX Baxter
$82.34 /

-0.42 (-0.51%)

ARWR Arrowhead
$73.96 /

-0.83 (-1.11%)

ARVN Arvinas
$65.15 /

-0.78 (-1.18%)

APLT Applied Therapeutics
$18.57 /

+1.06 (+6.05%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

ZYXI Zynex
$14.12 /

-0.61 (-4.14%)

SIOX Sio Gene Therapies
$2.22 /

+0.01 (+0.45%)

PACB Pacific Biosciences
$25.68 /

-0.1 (-0.39%)

MRNA Moderna
$169.25 /

+5.16 (+3.14%)

EAR Eargo
$32.10 /

-1.12 (-3.37%)

CVAC CureVac
$115.64 /

+1.27 (+1.11%)

CLPT ClearPoint Neuro
$18.07 /

-0.38 (-2.06%)

BSX Boston Scientific
$43.03 /

+0.215 (+0.50%)

BNTX BioNTech
$197.53 /

+2.64 (+1.35%)

AMWL Amwell
$11.89 /

+0.38 (+3.30%)

ALGN Align Technology
$594.91 /

-9.47 (-1.57%)

ABBV AbbVie
$114.56 /

-1.35 (-1.16%)

Conference/Events
UBS to hold a virtual conference » 04:55
05/25/21
05/25
04:55
05/25/21
04:55
NBTX

Nanobiotix

$16.16 /

+ (+0.00%)

, MRNA

Moderna

$164.12 /

+2.565 (+1.59%)

, TELA

Tela Bio

$13.25 /

-0.05 (-0.38%)

, ICLR

Icon

$232.11 /

+1.2 (+0.52%)

, AMWL

Amwell

$11.54 /

-0.16 (-1.37%)

, BRKR

Bruker

$69.74 /

+0.64 (+0.93%)

, SIOX

Sio Gene Therapies

$2.22 /

+0.015 (+0.68%)

, BMRN

BioMarin

$77.49 /

-0.63 (-0.81%)

, NVS

Novartis

$88.00 /

-0.065 (-0.07%)

, TERN

Terns Pharmaceuticals

$15.80 /

-0.11 (-0.69%)

, EAR

Eargo

$33.22 /

+1.17 (+3.65%)

, JAZZ

Jazz Pharmaceuticals

$178.88 /

-1.08 (-0.60%)

, TNDM

TNDM

/

+

, BAYRY

Bayer

$17.19 /

+0.16 (+0.94%)

, ANIK

Anika Therapeutics

$44.12 /

+0.11 (+0.25%)

, CVAC

CureVac

$114.37 /

-0.875 (-0.76%)

, BSX

Boston Scientific

$42.81 /

+0.705 (+1.67%)

, APLT

Applied Therapeutics

$17.51 /

+0.26 (+1.51%)

, ARVN

Arvinas

$65.93 /

-0.54 (-0.81%)

, PACB

Pacific Biosciences

$25.78 /

+0.2 (+0.78%)

, ABBV

AbbVie

$115.91 /

-0.2 (-0.17%)

, ZYXI

Zynex

$14.72 /

-0.08 (-0.54%)

, BAX

Baxter

$82.75 /

-0.31 (-0.37%)

, KOD

Kodiak Sciences

$81.22 /

+0.81 (+1.01%)

, ARWR

Arrowhead

$74.77 /

+0.64 (+0.86%)

, CUTR

Cutera

$38.15 /

-0.17 (-0.44%)

, TVTY

Tivity Health

$25.85 /

+0.63 (+2.50%)

, PTCT

PTC Therapeutics

$39.14 /

-0.34 (-0.86%)

, CTLT

Catalent

$102.55 /

+0.76 (+0.75%)

, RHHBY

Roche

$43.16 /

-0.09 (-0.21%)

, CLPT

ClearPoint Neuro

$18.37 /

-0.3 (-1.61%)

, BNTX

BioNTech

$194.87 /

-0.68 (-0.35%)

, ALGN

Align Technology

$604.00 /

+12.52 (+2.12%)

, DBTX

Decibel Therapeutics

$8.06 /

-0.175 (-2.13%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2021 to be held on May 24-26.Webcast Link

ShowHide Related Items >><<
ZYXI Zynex
$14.72 /

-0.08 (-0.54%)

TVTY Tivity Health
$25.85 /

+0.63 (+2.50%)

TNDM TNDM
/

+

TERN Terns Pharmaceuticals
$15.80 /

-0.11 (-0.69%)

TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

RHHBY Roche
$43.16 /

-0.09 (-0.21%)

PTCT PTC Therapeutics
$39.14 /

-0.34 (-0.86%)

PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

NVS Novartis
$88.00 /

-0.065 (-0.07%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

KOD Kodiak Sciences
$81.22 /

+0.81 (+1.01%)

JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

ICLR Icon
$232.11 /

+1.2 (+0.52%)

DBTX Decibel Therapeutics
$8.06 /

-0.175 (-2.13%)

CVAC CureVac
$114.37 /

-0.875 (-0.76%)

CUTR Cutera
$38.15 /

-0.17 (-0.44%)

CTLT Catalent
$102.55 /

+0.76 (+0.75%)

CLPT ClearPoint Neuro
$18.37 /

-0.3 (-1.61%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BRKR Bruker
$69.74 /

+0.64 (+0.93%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

BAX Baxter
$82.75 /

-0.31 (-0.37%)

ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

ARVN Arvinas
$65.93 /

-0.54 (-0.81%)

APLT Applied Therapeutics
$17.51 /

+0.26 (+1.51%)

AMWL Amwell
$11.54 /

-0.16 (-1.37%)

ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
MRNA Moderna
$164.12 /

+2.565 (+1.59%)

05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
05/07/21 Goldman Sachs
Moderna price target raised to $228 from $206 at Goldman Sachs
05/06/21 Piper Sandler
Moderna price target lowered to $231 from $234 at Piper Sandler
TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

04/12/21 Piper Sandler
Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
03/25/21 Canaccord
Tela Bio pieces in place for accelerating growth, says Canaccord
01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
ICLR Icon
$232.11 /

+1.2 (+0.52%)

05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/03/21 Mizuho
Icon price target raised to $242 from $217 at Mizuho
04/29/21 Credit Suisse
Icon price target raised to $245 from $240 at Credit Suisse
04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
AMWL Amwell
$11.54 /

-0.16 (-1.37%)

05/17/21 Guggenheim
Amwell upgraded to Buy from Neutral at Guggenheim
05/13/21 Piper Sandler
Amwell price target lowered to $20 from $30 at Piper Sandler
05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
BRKR Bruker
$69.74 /

+0.64 (+0.93%)

05/06/21 BTIG
Bruker price target raised to $80 from $73 at BTIG
05/06/21 SVB Leerink
Bruker price target raised to $80 from $70 at SVB Leerink
02/17/21 Stifel
Bruker price target raised to $65 from $48 at Stifel
02/17/21 Citi
Bruker price target raised to $65 from $57 at Citi
SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

04/30/21 Wedbush
BioMarin's Q1 revenue was better than expected, says Wedbush
04/26/21 Credit Suisse
BioMarin assumed with an Outperform at Credit Suisse
03/04/21 Guggenheim
BioMarin assumed at Buy from Neutral at Guggenheim
03/01/21 Evercore ISI
BioMarin upgraded to Outperform from In Line at Evercore ISI
NVS Novartis
$88.00 /

-0.065 (-0.07%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
TERN Terns Pharmaceuticals
$15.80 /

-0.11 (-0.69%)

03/02/21 Cowen
Terns initiated with Outperform on NASH potential at Cowen
03/02/21 JPMorgan
Terns Pharmaceuticals initiated with an Overweight at JPMorgan
03/02/21 Cowen
Terns Pharmaceuticals initiated with an Outperform at Cowen
03/02/21 Goldman Sachs
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs
EAR Eargo
$33.22 /

+1.17 (+3.65%)

05/13/21 Wells Fargo
Eargo price target lowered to $52 from $68 at Wells Fargo
05/12/21 JPMorgan
JPMorgan sees four 'compelling' MedTech opportunities after selloff
01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
TNDM TNDM
/

+

05/24/21 Barclays
Tandem Diabetes initiated with an Underweight at Barclays
05/06/21 SVB Leerink
Tandem Diabetes price target raised to $102 from $95 at SVB Leerink
05/06/21 Oppenheimer
Tandem Diabetes price target raised to $135 from $130 at Oppenheimer
05/06/21 Piper Sandler
Tandem Diabetes remains a 'name to buy' after Q1 beat, says Piper Sandler
BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

05/19/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
05/19/21 JPMorgan
JPMorgan upgrades Bayer to Overweight with earnings at 'turning point'
05/18/21 JPMorgan
Bayer upgraded to Overweight from Neutral at JPMorgan
05/14/21 Berenberg
Bayer price target raised to EUR 74 from EUR 68 at Berenberg
ANIK Anika Therapeutics
$44.12 /

+0.11 (+0.25%)

12/16/20 Barrington
Anika Therapeutics upgraded to Outperform with $43 target at Barrington
12/16/20 Barrington
Anika Therapeutics upgraded to Outperform from Market Perform at Barrington
CVAC CureVac
$114.37 /

-0.875 (-0.76%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

05/24/21 Barclays
Boston Scientific initiated with an Overweight at Barclays
05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Truist
Boston Scientific price target raised to $50 from $42 at Truist
04/29/21 Canaccord
Boston Scientific price target raised to $49 from $44 at Canaccord
APLT Applied Therapeutics
$17.51 /

+0.26 (+1.51%)

11/17/20 Barclays
Applied Therapeutics price target lowered to $44 from $64 at Barclays
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
ARVN Arvinas
$65.93 /

-0.54 (-0.81%)

05/20/21 UBS
Arvinas initiated with a Buy at UBS
04/21/21 Truist
Truist starts Arvinas with a Buy on PROTACs potential
04/21/21 Truist
Arvinas initiated with a Buy at Truist
03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
ZYXI Zynex
$14.72 /

-0.08 (-0.54%)

04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
02/26/21 B. Riley
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
02/26/21 B. Riley
Zynex downgraded to Neutral from Buy at B. Riley Securities
BAX Baxter
$82.75 /

-0.31 (-0.37%)

05/24/21 Barclays
Baxter initiated with an Equal Weight at Barclays
04/30/21 Citi
Baxter price target raised to $98 from $94 at Citi
04/29/21 Piper Sandler
Baxter price target raised to $85 from $80 at Piper Sandler
03/26/21 JPMorgan
Baxter a 'stock to own' into earnings and beyond, says JPMorgan
KOD Kodiak Sciences
$81.22 /

+0.81 (+1.01%)

05/11/21 Roth Capital
Roth Capital upgrades Kodiak Sciences to Buy on recent selloff
05/11/21 Roth Capital
Kodiak Sciences upgraded to Buy from Neutral at Roth Capital
05/11/21 BMO Capital
Kodiak Sciences price target lowered to $104 from $138 at BMO Capital
05/11/21 Barclays
Kodiak Sciences price target lowered to $86 from $90 at Barclays
ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

02/08/21 B. Riley
Arrowhead price target raised to $106 from $98 at B. Riley Securities
02/08/21 Citi
Arrowhead price target raised to $110 from $90 at Citi
02/05/21 Chardan
Arrowhead price target raised to $97 from $81 at Chardan
02/05/21 H.C. Wainwright
Arrowhead price target raised to $95 from $90 at H.C. Wainwright
CUTR Cutera
$38.15 /

-0.17 (-0.44%)

03/05/21 Piper Sandler
Cutera price target raised to $42 from $38 at Piper Sandler
02/18/21 Piper Sandler
Cutera price target raised to $38 from $28 at Piper Sandler
11/05/20 Piper Sandler
Cutera price target raised to $28 from $22 at Piper Sandler
09/14/20 Stephens
Cutera price target raised to $24 from $18 at Stephens
TVTY Tivity Health
$25.85 /

+0.63 (+2.50%)

02/25/21 Barrington
Tivity Health price target raised to $32 from $28 at Barrington
02/25/21 Piper Sandler
Tivity Health price target raised to $27 from $16 at Piper Sandler
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform with $19 target at Credit Suisse
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform from Neutral at Credit Suisse
PTCT PTC Therapeutics
$39.14 /

-0.34 (-0.86%)

05/17/21 Truist
PTC Therapeutics price target lowered to $65 from $75 at Truist
04/26/21 Credit Suisse
PTC Therapeutics assumed with a Neutral at Credit Suisse
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
CTLT Catalent
$102.55 /

+0.76 (+0.75%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
RHHBY Roche
$43.16 /

-0.09 (-0.21%)

05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
CLPT ClearPoint Neuro
$18.37 /

-0.3 (-1.61%)

03/18/21 Lake Street
Lake Street starts ClearPoint Neuro at Buy, sees 'billion-dollar' cap potential
03/18/21 Lake Street
ClearPoint Neuro initiated with a Buy at Lake Street
02/22/21 B. Riley
ClearPoint Neuro price target raised to $38 from $23 at B. Riley Securities
01/22/21 B. Riley
ClearPoint Neuro price target raised to $23 from $18 at B. Riley Securities
BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21
Fly Intel: Top five analyst downgrades
ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

04/29/21 SVB Leerink
Align Technology price target raised to $770 from $690 at SVB Leerink
04/29/21 Credit Suisse
Align Technology price target raised to $715 from $693 at Credit Suisse
04/29/21 Stifel
Align Technology price target raised to $750 from $650 at Stifel
04/29/21 Baird
Align Technology price target raised to $745 from $655 at Baird
DBTX Decibel Therapeutics
$8.06 /

-0.175 (-2.13%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
ZYXI Zynex
$14.72 /

-0.08 (-0.54%)

TVTY Tivity Health
$25.85 /

+0.63 (+2.50%)

TNDM TNDM
/

+

TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

RHHBY Roche
$43.16 /

-0.09 (-0.21%)

PTCT PTC Therapeutics
$39.14 /

-0.34 (-0.86%)

PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

NVS Novartis
$88.00 /

-0.065 (-0.07%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

KOD Kodiak Sciences
$81.22 /

+0.81 (+1.01%)

JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

ICLR Icon
$232.11 /

+1.2 (+0.52%)

EAR Eargo
$33.22 /

+1.17 (+3.65%)

CUTR Cutera
$38.15 /

-0.17 (-0.44%)

CTLT Catalent
$102.55 /

+0.76 (+0.75%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BRKR Bruker
$69.74 /

+0.64 (+0.93%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

BAX Baxter
$82.75 /

-0.31 (-0.37%)

ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

ARVN Arvinas
$65.93 /

-0.54 (-0.81%)

APLT Applied Therapeutics
$17.51 /

+0.26 (+1.51%)

AMWL Amwell
$11.54 /

-0.16 (-1.37%)

ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

  • 19
    Feb
  • 12
    Feb
  • 12
    Feb
  • 05
    Feb
  • 28
    Jan
  • 15
    Jan
  • 16
    Dec
  • 11
    Dec
  • 23
    Nov
  • 18
    Nov
  • 11
    Nov
  • 21
    Oct
  • 16
    Oct
  • 17
    Sep
  • 12
    Aug
  • 14
    Aug
  • 23
    Jul
  • 15
    Jul
  • 26
    Jun
  • 11
    Jun
RHHBY Roche
$43.16 /

-0.09 (-0.21%)

PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

NVS Novartis
$88.00 /

-0.065 (-0.07%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

ICLR Icon
$232.11 /

+1.2 (+0.52%)

CVAC CureVac
$114.37 /

-0.875 (-0.76%)

CTLT Catalent
$102.55 /

+0.76 (+0.75%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

BAX Baxter
$82.75 /

-0.31 (-0.37%)

ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

TERN Terns Pharmaceuticals
$15.80 /

-0.11 (-0.69%)

SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

RHHBY Roche
$43.16 /

-0.09 (-0.21%)

PTCT PTC Therapeutics
$39.14 /

-0.34 (-0.86%)

NVS Novartis
$88.00 /

-0.065 (-0.07%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

JAZZ Jazz Pharmaceuticals
$178.88 /

-1.08 (-0.60%)

ICLR Icon
$232.11 /

+1.2 (+0.52%)

DBTX Decibel Therapeutics
$8.06 /

-0.175 (-2.13%)

CVAC CureVac
$114.37 /

-0.875 (-0.76%)

CTLT Catalent
$102.55 /

+0.76 (+0.75%)

CLPT ClearPoint Neuro
$18.37 /

-0.3 (-1.61%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BRKR Bruker
$69.74 /

+0.64 (+0.93%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

BMRN BioMarin
$77.49 /

-0.63 (-0.81%)

BAYRY Bayer
$17.19 /

+0.16 (+0.94%)

BAX Baxter
$82.75 /

-0.31 (-0.37%)

ARWR Arrowhead
$74.77 /

+0.64 (+0.86%)

ARVN Arvinas
$65.93 /

-0.54 (-0.81%)

APLT Applied Therapeutics
$17.51 /

+0.26 (+1.51%)

AMWL Amwell
$11.54 /

-0.16 (-1.37%)

ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

ZYXI Zynex
$14.72 /

-0.08 (-0.54%)

SIOX Sio Gene Therapies
$2.22 /

+0.015 (+0.68%)

PACB Pacific Biosciences
$25.78 /

+0.2 (+0.78%)

MRNA Moderna
$164.12 /

+2.565 (+1.59%)

EAR Eargo
$33.22 /

+1.17 (+3.65%)

CVAC CureVac
$114.37 /

-0.875 (-0.76%)

CLPT ClearPoint Neuro
$18.37 /

-0.3 (-1.61%)

BSX Boston Scientific
$42.81 /

+0.705 (+1.67%)

BNTX BioNTech
$194.87 /

-0.68 (-0.35%)

AMWL Amwell
$11.54 /

-0.16 (-1.37%)

ALGN Align Technology
$604.00 /

+12.52 (+2.12%)

ABBV AbbVie
$115.91 /

-0.2 (-0.17%)

Conference/Events
UBS to hold a virtual conference » 10:02
05/24/21
05/24
10:02
05/24/21
10:02
NBTX

Nanobiotix

$16.16 /

+ (+0.00%)

, MRNA

Moderna

$164.80 /

+3.245 (+2.01%)

, TELA

Tela Bio

$13.25 /

-0.05 (-0.38%)

, ICLR

Icon

$232.40 /

+1.49 (+0.65%)

, AMWL

Amwell

$11.69 /

-0.01 (-0.09%)

, BRKR

Bruker

$69.47 /

+0.37 (+0.54%)

, SIOX

Sio Gene Therapies

$2.19 /

-0.015 (-0.68%)

, BMRN

BioMarin

$78.16 /

+0.04 (+0.05%)

, NVS

Novartis

$88.27 /

+0.205 (+0.23%)

, TERN

Terns Pharmaceuticals

$15.89 /

-0.02 (-0.13%)

, EAR

Eargo

$32.32 /

+0.27 (+0.84%)

, JAZZ

Jazz Pharmaceuticals

$180.90 /

+0.94 (+0.52%)

, TNDM

TNDM

/

+

, BAYRY

Bayer

$17.03 /

+0.065 (+0.38%)

, ANIK

Anika Therapeutics

$44.01 /

+ (+0.00%)

, CVAC

CureVac

$117.23 /

+1.99 (+1.73%)

, BSX

Boston Scientific

$42.27 /

+0.17 (+0.40%)

, APLT

Applied Therapeutics

$17.22 /

-0.03 (-0.17%)

, ARVN

Arvinas

$66.28 /

-0.19 (-0.29%)

, PACB

Pacific Biosciences

$26.66 /

+1.08 (+4.22%)

, ABBV

AbbVie

$115.99 /

-0.12 (-0.10%)

, ZYXI

Zynex

$15.03 /

+0.23 (+1.55%)

, BAX

Baxter

$82.93 /

-0.13 (-0.16%)

, KOD

Kodiak Sciences

$80.94 /

+0.53 (+0.66%)

, ARWR

Arrowhead

$75.00 /

+0.87 (+1.17%)

, CUTR

Cutera

$38.64 /

+0.32 (+0.84%)

, TVTY

Tivity Health

$25.26 /

+0.04 (+0.16%)

, PTCT

PTC Therapeutics

$39.80 /

+0.32 (+0.81%)

, CTLT

Catalent

$101.85 /

+0.06 (+0.06%)

, RHHBY

Roche

$43.25 /

+0.32 (+0.75%)

, CLPT

ClearPoint Neuro

$18.55 /

-0.12 (-0.64%)

, BNTX

BioNTech

$199.00 /

+3.45 (+1.76%)

, ALGN

Align Technology

$601.02 /

+9.54 (+1.61%)

, DBTX

Decibel Therapeutics

$8.08 /

-0.15 (-1.82%)

Global Healthcare Virtual…

Global Healthcare Virtual Conference 2021 to be held on May 24-26.Webcast Link

ShowHide Related Items >><<
ZYXI Zynex
$15.03 /

+0.23 (+1.55%)

TVTY Tivity Health
$25.26 /

+0.04 (+0.16%)

TNDM TNDM
/

+

TERN Terns Pharmaceuticals
$15.89 /

-0.02 (-0.13%)

TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

RHHBY Roche
$43.25 /

+0.32 (+0.75%)

PTCT PTC Therapeutics
$39.80 /

+0.32 (+0.81%)

PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

NVS Novartis
$88.27 /

+0.205 (+0.23%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

KOD Kodiak Sciences
$80.94 /

+0.53 (+0.66%)

JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

ICLR Icon
$232.40 /

+1.49 (+0.65%)

DBTX Decibel Therapeutics
$8.08 /

-0.15 (-1.82%)

CVAC CureVac
$117.23 /

+1.99 (+1.73%)

CUTR Cutera
$38.64 /

+0.32 (+0.84%)

CTLT Catalent
$101.85 /

+0.06 (+0.06%)

CLPT ClearPoint Neuro
$18.55 /

-0.12 (-0.64%)

BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

BRKR Bruker
$69.47 /

+0.37 (+0.54%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

BAX Baxter
$82.93 /

-0.13 (-0.16%)

ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

ARVN Arvinas
$66.28 /

-0.19 (-0.29%)

APLT Applied Therapeutics
$17.22 /

-0.03 (-0.17%)

AMWL Amwell
$11.69 /

-0.01 (-0.09%)

ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

01/05/21 Evercore ISI
Nanobiotix initiated with an Outperform at Evercore ISI
01/05/21 UBS
Nanobiotix initiated with a Buy at UBS
MRNA Moderna
$164.80 /

+3.245 (+2.01%)

05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
05/07/21 Goldman Sachs
Moderna price target raised to $228 from $206 at Goldman Sachs
05/06/21 Piper Sandler
Moderna price target lowered to $231 from $234 at Piper Sandler
TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

04/12/21 Piper Sandler
Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
03/25/21 Canaccord
Tela Bio pieces in place for accelerating growth, says Canaccord
01/14/21 Piper Sandler
Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
ICLR Icon
$232.40 /

+1.49 (+0.65%)

05/10/21 Truist
PRA Health downgraded to Hold from Buy at Truist
05/03/21 Mizuho
Icon price target raised to $242 from $217 at Mizuho
04/29/21 Credit Suisse
Icon price target raised to $245 from $240 at Credit Suisse
04/20/21 Baird
PRA Health downgraded to Neutral from Outperform at Baird
AMWL Amwell
$11.69 /

-0.01 (-0.09%)

05/17/21 Guggenheim
Amwell upgraded to Buy from Neutral at Guggenheim
05/13/21 Piper Sandler
Amwell price target lowered to $20 from $30 at Piper Sandler
05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
BRKR Bruker
$69.47 /

+0.37 (+0.54%)

05/06/21 BTIG
Bruker price target raised to $80 from $73 at BTIG
05/06/21 SVB Leerink
Bruker price target raised to $80 from $70 at SVB Leerink
02/17/21 Stifel
Bruker price target raised to $65 from $48 at Stifel
02/17/21 Citi
Bruker price target raised to $65 from $57 at Citi
SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

04/30/21 Wedbush
BioMarin's Q1 revenue was better than expected, says Wedbush
04/26/21 Credit Suisse
BioMarin assumed with an Outperform at Credit Suisse
03/04/21 Guggenheim
BioMarin assumed at Buy from Neutral at Guggenheim
03/01/21 Evercore ISI
BioMarin upgraded to Outperform from In Line at Evercore ISI
NVS Novartis
$88.27 /

+0.205 (+0.23%)

05/11/21 Morgan Stanley
Novartis price target lowered to CHF 99 from CHF 102 at Morgan Stanley
04/28/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 85 at JPMorgan
04/28/21 Oddo BHF
Novartis upgraded to Outperform from Neutral at Oddo BHF
04/19/21 UBS
Novartis price target raised to CHF 96 from CHF 95 at UBS
TERN Terns Pharmaceuticals
$15.89 /

-0.02 (-0.13%)

03/02/21 Cowen
Terns initiated with Outperform on NASH potential at Cowen
03/02/21 JPMorgan
Terns Pharmaceuticals initiated with an Overweight at JPMorgan
03/02/21 Cowen
Terns Pharmaceuticals initiated with an Outperform at Cowen
03/02/21 Goldman Sachs
Terns Pharmaceuticals initiated with a Buy at Goldman Sachs
EAR Eargo
$32.32 /

+0.27 (+0.84%)

05/13/21 Wells Fargo
Eargo price target lowered to $52 from $68 at Wells Fargo
05/12/21 JPMorgan
JPMorgan sees four 'compelling' MedTech opportunities after selloff
01/13/21 Wells Fargo
Eargo price target raised to $60 from $53 at Wells Fargo
11/10/20
Fly Intel: Top five analyst initiations
JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

05/19/21
Fly Intel: Top five analyst initiations
05/19/21 JPMorgan
Jazz Pharmaceuticals resumed with an Overweight at JPMorgan
05/17/21 H.C. Wainwright
Jazz Pharmaceuticals price target raised to $212 from $207 at H.C. Wainwright
04/21/21 Cantor Fitzgerald
Jazz Pharmaceuticals price target raised to $198 from $185 at Cantor Fitzgerald
TNDM TNDM
/

+

05/06/21 SVB Leerink
Tandem Diabetes price target raised to $102 from $95 at SVB Leerink
05/06/21 Oppenheimer
Tandem Diabetes price target raised to $135 from $130 at Oppenheimer
05/06/21 Piper Sandler
Tandem Diabetes remains a 'name to buy' after Q1 beat, says Piper Sandler
03/12/21 Piper Sandler
Tandem Diabetes competition concerns overblown, says Piper Sandler
BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

05/19/21 Morgan Stanley
Bayer price target raised to EUR 71 from EUR 70 at Morgan Stanley
05/19/21 JPMorgan
JPMorgan upgrades Bayer to Overweight with earnings at 'turning point'
05/18/21 JPMorgan
Bayer upgraded to Overweight from Neutral at JPMorgan
05/14/21 Berenberg
Bayer price target raised to EUR 74 from EUR 68 at Berenberg
ANIK Anika Therapeutics
$44.01 /

+ (+0.00%)

12/16/20 Barrington
Anika Therapeutics upgraded to Outperform with $43 target at Barrington
12/16/20 Barrington
Anika Therapeutics upgraded to Outperform from Market Perform at Barrington
CVAC CureVac
$117.23 /

+1.99 (+1.73%)

04/26/21 Credit Suisse
CureVac assumed with an Underperform at Credit Suisse
04/26/21 Guggenheim
CureVac initiated with a Buy at Guggenheim
01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

05/06/21 Raymond James
Abiomed could face new competition from Boston Scientific, says Raymond James
04/29/21 Truist
Boston Scientific price target raised to $50 from $42 at Truist
04/29/21 Canaccord
Boston Scientific price target raised to $49 from $44 at Canaccord
04/29/21 Wells Fargo
Boston Scientific price target raised to $50 from $42 at Wells Fargo
APLT Applied Therapeutics
$17.22 /

-0.03 (-0.17%)

11/17/20 Barclays
Applied Therapeutics price target lowered to $44 from $64 at Barclays
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
10/08/20 Truist
Applied Therapeutics initiated with a Buy at Truist
ARVN Arvinas
$66.28 /

-0.19 (-0.29%)

05/20/21 UBS
Arvinas initiated with a Buy at UBS
04/21/21 Truist
Truist starts Arvinas with a Buy on PROTACs potential
04/21/21 Truist
Arvinas initiated with a Buy at Truist
03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

03/31/21 Piper Sandler
Illumina should be bought on weakness from FTC challenge, says Piper Sandler
02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

05/19/21 Piper Sandler
Piper 'incrementally bullish' on Biohaven, AbbVie migraine drugs
05/13/21 Cantor Fitzgerald
Soliton downgraded to Neutral from Overweight at Cantor Fitzgerald
05/11/21 Maxim
Soliton downgraded to Hold from Buy at Maxim
05/03/21 Mizuho
AbbVie price target raised to $128 from $126 at Mizuho
ZYXI Zynex
$15.03 /

+0.23 (+1.55%)

04/29/21 Piper Sandler
Zynex price target lowered to $15 from $19 at Piper Sandler
03/09/21 Northland
Zynex upgraded to Outperform from Market Perform at Northland
02/26/21 B. Riley
B. Riley downgrades Zynex to Neutral on 'deteriorating profitability'
02/26/21 B. Riley
Zynex downgraded to Neutral from Buy at B. Riley Securities
BAX Baxter
$82.93 /

-0.13 (-0.16%)

04/30/21 Citi
Baxter price target raised to $98 from $94 at Citi
04/29/21 Piper Sandler
Baxter price target raised to $85 from $80 at Piper Sandler
03/26/21 JPMorgan
Baxter a 'stock to own' into earnings and beyond, says JPMorgan
03/22/21 Benchmark
Omnicell price target raised to $155 from $140 at Benchmark
KOD Kodiak Sciences
$80.94 /

+0.53 (+0.66%)

05/11/21 Roth Capital
Roth Capital upgrades Kodiak Sciences to Buy on recent selloff
05/11/21 Roth Capital
Kodiak Sciences upgraded to Buy from Neutral at Roth Capital
05/11/21 BMO Capital
Kodiak Sciences price target lowered to $104 from $138 at BMO Capital
05/11/21 Barclays
Kodiak Sciences price target lowered to $86 from $90 at Barclays
ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

02/08/21 B. Riley
Arrowhead price target raised to $106 from $98 at B. Riley Securities
02/08/21 Citi
Arrowhead price target raised to $110 from $90 at Citi
02/05/21 Chardan
Arrowhead price target raised to $97 from $81 at Chardan
02/05/21 H.C. Wainwright
Arrowhead price target raised to $95 from $90 at H.C. Wainwright
CUTR Cutera
$38.64 /

+0.32 (+0.84%)

03/05/21 Piper Sandler
Cutera price target raised to $42 from $38 at Piper Sandler
02/18/21 Piper Sandler
Cutera price target raised to $38 from $28 at Piper Sandler
11/05/20 Piper Sandler
Cutera price target raised to $28 from $22 at Piper Sandler
09/14/20 Stephens
Cutera price target raised to $24 from $18 at Stephens
TVTY Tivity Health
$25.26 /

+0.04 (+0.16%)

02/25/21 Barrington
Tivity Health price target raised to $32 from $28 at Barrington
02/25/21 Piper Sandler
Tivity Health price target raised to $27 from $16 at Piper Sandler
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform with $19 target at Credit Suisse
01/15/21 Credit Suisse
Tivity Health downgraded to Underperform from Neutral at Credit Suisse
PTCT PTC Therapeutics
$39.80 /

+0.32 (+0.81%)

05/17/21 Truist
PTC Therapeutics price target lowered to $65 from $75 at Truist
04/26/21 Credit Suisse
PTC Therapeutics assumed with a Neutral at Credit Suisse
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
CTLT Catalent
$101.85 /

+0.06 (+0.06%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
RHHBY Roche
$43.25 /

+0.32 (+0.75%)

05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
CLPT ClearPoint Neuro
$18.55 /

-0.12 (-0.64%)

03/18/21 Lake Street
Lake Street starts ClearPoint Neuro at Buy, sees 'billion-dollar' cap potential
03/18/21 Lake Street
ClearPoint Neuro initiated with a Buy at Lake Street
02/22/21 B. Riley
ClearPoint Neuro price target raised to $38 from $23 at B. Riley Securities
01/22/21 B. Riley
ClearPoint Neuro price target raised to $23 from $18 at B. Riley Securities
BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

05/18/21
Fly Intel: Top five analyst initiations
05/18/21 Goldman Sachs
BioNTech initiated with a Neutral at Goldman Sachs
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21
Fly Intel: Top five analyst downgrades
ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

04/29/21 SVB Leerink
Align Technology price target raised to $770 from $690 at SVB Leerink
04/29/21 Credit Suisse
Align Technology price target raised to $715 from $693 at Credit Suisse
04/29/21 Stifel
Align Technology price target raised to $750 from $650 at Stifel
04/29/21 Baird
Align Technology price target raised to $745 from $655 at Baird
DBTX Decibel Therapeutics
$8.08 /

-0.15 (-1.82%)

03/09/21 Citi
Decibel Therapeutics initiated with a Buy at Citi
03/09/21 SVB Leerink
Decibel Therapeutics initiated with an Outperform at SVB Leerink
03/09/21 Barclays
Decibel Therapeutics initiated with an Overweight at Barclays
03/09/21 BMO Capital
Decibel Therapeutics initiated with an Outperform at BMO Capital
ZYXI Zynex
$15.03 /

+0.23 (+1.55%)

TVTY Tivity Health
$25.26 /

+0.04 (+0.16%)

TNDM TNDM
/

+

TELA Tela Bio
$13.25 /

-0.05 (-0.38%)

SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

RHHBY Roche
$43.25 /

+0.32 (+0.75%)

PTCT PTC Therapeutics
$39.80 /

+0.32 (+0.81%)

PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

NVS Novartis
$88.27 /

+0.205 (+0.23%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

KOD Kodiak Sciences
$80.94 /

+0.53 (+0.66%)

JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

ICLR Icon
$232.40 /

+1.49 (+0.65%)

EAR Eargo
$32.32 /

+0.27 (+0.84%)

CUTR Cutera
$38.64 /

+0.32 (+0.84%)

CTLT Catalent
$101.85 /

+0.06 (+0.06%)

BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

BRKR Bruker
$69.47 /

+0.37 (+0.54%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

BAX Baxter
$82.93 /

-0.13 (-0.16%)

ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

ARVN Arvinas
$66.28 /

-0.19 (-0.29%)

APLT Applied Therapeutics
$17.22 /

-0.03 (-0.17%)

AMWL Amwell
$11.69 /

-0.01 (-0.09%)

ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

  • 19
    Feb
  • 12
    Feb
  • 12
    Feb
  • 05
    Feb
  • 28
    Jan
  • 15
    Jan
  • 16
    Dec
  • 11
    Dec
  • 23
    Nov
  • 18
    Nov
  • 11
    Nov
  • 21
    Oct
  • 16
    Oct
  • 17
    Sep
  • 12
    Aug
  • 14
    Aug
  • 23
    Jul
  • 15
    Jul
  • 26
    Jun
  • 11
    Jun
RHHBY Roche
$43.25 /

+0.32 (+0.75%)

PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

NVS Novartis
$88.27 /

+0.205 (+0.23%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

ICLR Icon
$232.40 /

+1.49 (+0.65%)

CVAC CureVac
$117.23 /

+1.99 (+1.73%)

CTLT Catalent
$101.85 /

+0.06 (+0.06%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

BAX Baxter
$82.93 /

-0.13 (-0.16%)

ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

TERN Terns Pharmaceuticals
$15.89 /

-0.02 (-0.13%)

SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

RHHBY Roche
$43.25 /

+0.32 (+0.75%)

PTCT PTC Therapeutics
$39.80 /

+0.32 (+0.81%)

NVS Novartis
$88.27 /

+0.205 (+0.23%)

NBTX Nanobiotix
$16.16 /

+ (+0.00%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

JAZZ Jazz Pharmaceuticals
$180.90 /

+0.94 (+0.52%)

ICLR Icon
$232.40 /

+1.49 (+0.65%)

DBTX Decibel Therapeutics
$8.08 /

-0.15 (-1.82%)

CVAC CureVac
$117.23 /

+1.99 (+1.73%)

CTLT Catalent
$101.85 /

+0.06 (+0.06%)

CLPT ClearPoint Neuro
$18.55 /

-0.12 (-0.64%)

BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

BRKR Bruker
$69.47 /

+0.37 (+0.54%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

BMRN BioMarin
$78.16 /

+0.04 (+0.05%)

BAYRY Bayer
$17.03 /

+0.065 (+0.38%)

BAX Baxter
$82.93 /

-0.13 (-0.16%)

ARWR Arrowhead
$75.00 /

+0.87 (+1.17%)

ARVN Arvinas
$66.28 /

-0.19 (-0.29%)

APLT Applied Therapeutics
$17.22 /

-0.03 (-0.17%)

AMWL Amwell
$11.69 /

-0.01 (-0.09%)

ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

ZYXI Zynex
$15.03 /

+0.23 (+1.55%)

SIOX Sio Gene Therapies
$2.19 /

-0.015 (-0.68%)

PACB Pacific Biosciences
$26.66 /

+1.08 (+4.22%)

MRNA Moderna
$164.80 /

+3.245 (+2.01%)

EAR Eargo
$32.32 /

+0.27 (+0.84%)

CVAC CureVac
$117.23 /

+1.99 (+1.73%)

CLPT ClearPoint Neuro
$18.55 /

-0.12 (-0.64%)

BSX Boston Scientific
$42.27 /

+0.17 (+0.40%)

BNTX BioNTech
$199.00 /

+3.45 (+1.76%)

AMWL Amwell
$11.69 /

-0.01 (-0.09%)

ALGN Align Technology
$601.02 /

+9.54 (+1.61%)

ABBV AbbVie
$115.99 /

-0.12 (-0.10%)

Over a month ago
Hot Stocks
Catalent names Thomas Castellano as CFO » 07:07
05/11/21
05/11
07:07
05/11/21
07:07
CTLT

Catalent

$104.86 /

-2.71 (-2.52%)

Catalent announced the…

Catalent announced the promotion of Thomas Castellano to serve as the company's Senior Vice President and Chief Financial Officer effective June 1, 2021, succeeding Wetteny Joseph who will be leaving the company to become the Chief Financial Officer of Zoetis Inc. "On behalf of the Board, our shareholders, and all of us at Catalent, we'd like to thank Wetteny for his long and dedicated service, and we wish him every success in his future endeavors," said John Chiminski, Chair and Chief Executive Officer. "We are delighted to recognize Tom's continuing contributions and development as a senior executive at Catalent, and I look forward to working with him in his new role. Today's smooth succession demonstrates the strength of Catalent's bench and our proactive planning and executive development efforts."

ShowHide Related Items >><<
CTLT Catalent
$104.86 /

-2.71 (-2.52%)

CTLT Catalent
$104.86 /

-2.71 (-2.52%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
CTLT Catalent
$104.86 /

-2.71 (-2.52%)

  • 23
    Nov
  • 11
    Jun
CTLT Catalent
$104.86 /

-2.71 (-2.52%)

CTLT Catalent
$104.86 /

-2.71 (-2.52%)

Conference/Events
Catalent participates in a conference call with JPMorgan » 13:25
05/06/21
05/06
13:25
05/06/21
13:25
CTLT

Catalent

$105.04 /

-1.49 (-1.40%)

Life Science Tools &…

Life Science Tools & Diagnostics Analyst Peterson holds a conference call with CEO Chiminski on May 6 at 2 pm hosted by JPMorgan.

ShowHide Related Items >><<
CTLT Catalent
$105.04 /

-1.49 (-1.40%)

CTLT Catalent
$105.04 /

-1.49 (-1.40%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
CTLT Catalent
$105.04 /

-1.49 (-1.40%)

  • 23
    Nov
  • 11
    Jun
CTLT Catalent
$105.04 /

-1.49 (-1.40%)

CTLT Catalent
$105.04 /

-1.49 (-1.40%)

Conference/Events
Catalent participates in a conference call with JPMorgan » 04:55
05/06/21
05/06
04:55
05/06/21
04:55
CTLT

Catalent

$106.26 /

+2.71 (+2.62%)

Life Science Tools &…

Life Science Tools & Diagnostics Analyst Peterson holds a conference call with CEO Chiminski on May 6 at 2 pm hosted by JPMorgan.

ShowHide Related Items >><<
CTLT Catalent
$106.26 /

+2.71 (+2.62%)

CTLT Catalent
$106.26 /

+2.71 (+2.62%)

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
CTLT Catalent
$106.26 /

+2.71 (+2.62%)

  • 23
    Nov
  • 11
    Jun
CTLT Catalent
$106.26 /

+2.71 (+2.62%)

CTLT Catalent
$106.26 /

+2.71 (+2.62%)

On The Fly
Fly Intel: Pre-market Movers » 09:05
05/04/21
05/04
09:05
05/04/21
09:05
BLRX

BioLineRx

/

+

, JOBS

51job

/

+

, CVS

CVS Health

/

+

, PFE

Pfizer

/

+

, UAA

Under Armour

/

+

, UA

Under Armour

/

+

, CTLT

Catalent

/

+

, WMG

Warner Music

/

+

, CMI

Cummins

/

+

, RCM

R1 RCM

/

+

, XPO

XPO Logistics

/

+

, MOS

Mosaic

/

+

, IRBT

iRobot

/

+

, SDC

SmileDirectClub

/

+

Check out this morning's…

ShowHide Related Items >><<
XPO XPO Logistics
/

+

WMG Warner Music
/

+

UAA Under Armour
/

+

SDC SmileDirectClub
/

+

RCM R1 RCM
/

+

PFE Pfizer
/

+

MOS Mosaic
/

+

JOBS 51job
/

+

IRBT iRobot
/

+

CVS CVS Health
/

+

CTLT Catalent
/

+

CMI Cummins
/

+

BLRX BioLineRx
/

+

BLRX BioLineRx
/

+

02/23/21 H.C. Wainwright
BioLineRx price target lowered to $19 from $22 at H.C. Wainwright
12/16/20 Oppenheimer
Oppenheimer continues to see BioLineRx as 'a bargain,' reiterates Outperform
12/16/20 H.C. Wainwright
BioLineRx pullback due to 'sell the news' reaction to data, says H.C. Wainwright
JOBS 51job
/

+

CVS CVS Health
/

+

04/19/21 Gordon Haskett
Encompass Health jet found back in home state of CVS, says Gordon Haskett
04/14/21 Truist
CVS Health price target raised to $88 from $80 at Truist
04/14/21 Morgan Stanley
CVS Health price target raised to $92 from $86 at Morgan Stanley
04/08/21 Gordon Haskett
Gordon Haskett highlights Encompass Health's 'interesting' Rhode Island trip
PFE Pfizer
/

+

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
UAA Under Armour
/

+

05/03/21 Jefferies
Under Armour footwear could be area of relative strength in Q1, says Jefferies
04/30/21
Fly Intel: Top five analyst upgrades
04/30/21 Williams Capital
Under Armour upgraded to Buy on improving outlook at Williams Trading
04/30/21 Williams Capital
Under Armour upgraded to Buy from Hold at Williams Trading
UA Under Armour
/

+

CTLT Catalent
/

+

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
WMG Warner Music
/

+

04/22/21 Jefferies
Warner Music initiated with a Hold at Jefferies
03/18/21 Redburn
Redburn sees 40% downside in Warner Music, starts with Sell rating
03/18/21
Fly Intel: Top five analyst initiations
03/18/21 Redburn
Warner Music initiated with a Sell at Redburn
CMI Cummins
/

+

04/13/21 Deutsche Bank
Cummins price target raised to $260 from $252 at Deutsche Bank
03/16/21 Jefferies
Jefferies sees upside to Cummins estimates amid more engine wins
03/16/21 Citi
Cummins price target raised to $315 from $265 at Citi
03/04/21 Jefferies
Jefferies upgrades Cummins to Buy on better near- and long-term outlook
RCM R1 RCM
/

+

02/16/21 KeyBanc
R1 RCM price target raised to $35 from $27 at KeyBanc
02/09/21 Cowen
R1 RCM price target raised to $33 from $22 at Cowen
01/08/21 Baird
Vocera downgraded to Neutral on valuation at Baird
12/09/20 RBC Capital
R1 RCM price target raised to $27 from $20 at RBC Capital
XPO XPO Logistics
/

+

04/30/21 Jefferies
XPO Logistics assumed with a Buy at Jefferies
04/21/21 Oppenheimer
XPO Logistics price target raised to $150 from $137 at Oppenheimer
04/15/21 Truist
XPO Logistics price target raised to $150 from $140 at Truist
04/15/21 Barclays
XPO Logistics upgraded to Overweight from Equal Weight at Barclays
MOS Mosaic
/

+

04/13/21
Fly Intel: Top five analyst upgrades
04/13/21 Berenberg
Mosaic upgraded to Buy from Hold at Berenberg
04/05/21 RBC Capital
Mosaic price target raised to $42 from $36 at RBC Capital
02/22/21 Barclays
Mosaic price target raised to $33 from $19 at Barclays
IRBT iRobot
/

+

02/12/21 Northland
iRobot price target raised to $140 from $120 at Northland
02/12/21 Citi
iRobot price target raised to $140 from $95 at Citi
02/11/21 JPMorgan
iRobot upgraded to Overweight from Neutral at JPMorgan
02/11/21 JPMorgan
iRobot upgraded to Overweight from Neutral at JPMorgan
SDC SmileDirectClub
/

+

05/04/21 Stifel
Stifel sees 'good' and 'bad' in SmileDirectClub's 'unexpected' pre-announcement
03/15/21 Piper Sandler
Align Technology Q1 update to move shares higher, says Piper Sandler
12/08/20 Wolfe Research
SmileDirectClub upgraded to Outperform from Peer Perform at Wolfe Research
11/24/20 JPMorgan
JPMorgan reiterates Overweight on SmileDirectClub after management meetings
XPO XPO Logistics
/

+

WMG Warner Music
/

+

UAA Under Armour
/

+

SDC SmileDirectClub
/

+

RCM R1 RCM
/

+

PFE Pfizer
/

+

MOS Mosaic
/

+

JOBS 51job
/

+

IRBT iRobot
/

+

CVS CVS Health
/

+

CTLT Catalent
/

+

CMI Cummins
/

+

BLRX BioLineRx
/

+

  • 20
    Jan
  • 09
    Dec
  • 24
    Nov
  • 23
    Nov
  • 19
    Nov
  • 11
    Jun
  • 03
    Jun
XPO XPO Logistics
/

+

WMG Warner Music
/

+

UAA Under Armour
/

+

SDC SmileDirectClub
/

+

PFE Pfizer
/

+

CVS CVS Health
/

+

CTLT Catalent
/

+

CMI Cummins
/

+

XPO XPO Logistics
/

+

UAA Under Armour
/

+

SDC SmileDirectClub
/

+

PFE Pfizer
/

+

MOS Mosaic
/

+

CVS CVS Health
/

+

CTLT Catalent
/

+

CMI Cummins
/

+

BLRX BioLineRx
/

+

UAA Under Armour
/

+

UA Under Armour
/

+

SDC SmileDirectClub
/

+

PFE Pfizer
/

+

MOS Mosaic
/

+

IRBT iRobot
/

+

CVS CVS Health
/

+

Earnings
Catalent raises FY21 revenue view to $3.875B-$3.975B from $3.8B-$3.95B » 07:16
05/04/21
05/04
07:16
05/04/21
07:16
CTLT

Catalent

/

+

FY21 revenue $3.89B. Sees…

FY21 revenue $3.89B. Sees Adjusted EBITDA for fiscal 2021 in the range of $975M-$1.015B, compared to the previous range of $950M-$1B; Adjusted Net Income for fiscal 2021 in the range of $500M-$540M, compared to the previous range of $475M-$525M. Cites higher net underlying demand for COVID-19 vaccines and treatments.

ShowHide Related Items >><<
CTLT Catalent
/

+

CTLT Catalent
/

+

04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
03/02/21 Argus
Catalent price target raised to $140 from $130 at Argus
02/03/21 UBS
Catalent price target raised to $135 from $115 at UBS
02/03/21 RBC Capital
Catalent price target raised to $137 from $125 at RBC Capital
CTLT Catalent
/

+

  • 23
    Nov
  • 11
    Jun
CTLT Catalent
/

+

CTLT Catalent
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.